IDiyas

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Sophie Perrin-Ninkovic

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 10.8

ph-index = 6

Forward Citations = 231(Granted Patents)


Location History:

  • Carlsbad, CA (US) (2006 - 2013)
  • La Jolla, CA (US) (2012 - 2022)

Company Filing History:

goldMedal16 out of 169 
 
Signal Pharmaceuticals, Inc.
 patents
silverMedal2 out of 549 
 
Celgene Corporation
 patents

Years Active: 2006-2025

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents
1. 12486281 - Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith (2025-12-02),
2. 11306101 - Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith (2022-04-19),
3. 11292796 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors (2022-04-05),
4. 10683298 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors (2020-06-16),
5. 10167290 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors (2019-01-01),
6. 9771371 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors (2017-09-26),
7. 9193692 - Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors (2015-11-24),
8. 9079900 - Methods of synthesis and purification of heteroaryl compounds (2015-07-14),
9. 8907087 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors (2014-12-09),
10. 8569494 - Methods of synthesis and purification of heteroaryl compounds (2013-10-29),
11. 8507492 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway (2013-08-13),
12. 8492381 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway (2013-07-23),
13. 8372976 - Methods of treatment comprising the administration of heteroaryl compounds (2013-02-12),
14. 8110578 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway (2012-02-07),
15. 7981893 - Heteroaryl compounds, compositions thereof, and methods of treatment therewith (2011-07-19),

Title: The Innovative Mind of Sophie Perrin-Ninkovic

Introduction: Sophie Perrin-Ninkovic is a pioneering inventor based in La Jolla, California, known for her groundbreaking contributions to various fields.

Latest Patents: Sophie Perrin-Ninkovic holds several patents in the areas of biotechnology, renewable energy, and sustainable materials, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Sophie Perrin-Ninkovic has worked with leading research institutions and universities to develop cutting-edge technologies that have the potential to revolutionize industries.

Collaborations: Throughout her career, Sophie Perrin-Ninkovic has collaborated with top companies, innovative startups, and renowned scientists to bring her inventions to life and make a lasting impact on society.

Conclusion: Sophie Perrin-Ninkovic's passion for innovation and her relentless pursuit of excellence have solidified her reputation as a visionary inventor at the forefront of technological advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…